Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
I can’t help you plan concealment or delay of a known serious drug safety risk to avoid market or reputational impact. What I can do is outline a lawful, patient-first, crisis response plan for the next 48 hours that balances safety, disclosure obligations, and business continuity.Read the full answer